Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
2025/12/02

DJ Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. $(DGX)$ slid 2.86% to $183.77 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33.

This was the stock's third consecutive day of losses.

Quest Diagnostics Inc. closed 6.98% short of its 52-week high of $197.55, which the company achieved on October 21st.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as UnitedHealth Group Inc. $(UNH)$ fell 1.99% to $323.21, IQVIA Holdings Inc. $(IQV)$ fell 0.67% to $228.47, and Centene Corp. $(CNC)$ fell 3.69% to $37.89.

Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 01, 2025 17:05 ET (22:05 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10